Investor Relations

Be part of this global company offering effective, long-lasting treatments for the growing epidemic of brain disorders. Invest now to bring this patented technological advancement to the world.

Initial in-house studies – Morries & Henderson (2015) – have shown 100% of patients treated with multi-watt infrared laser show improvement in a variety of neurological symptoms including headaches, insomnia, anxiety, memory, irritability and depression.

Since 2012 hundreds of patients have received treatments and continue to report long-lasting, persistent benefit after 6-7 years based on follow-up interviews.

Our strategy is two-pronged: to create and license brain health centers nationwide and provide our patented neuro laser protocol to approved facilities like universities, military, sports teams, medical community, and veterans administration in order to provide services to the millions of Americans impacted by TBI/CTE, depression, PTSD, dementia, Alzheimer’s disease, and Parkinson’s disease.

We have a unique patented infrared laser treatment protocol (held by the Neuro-Laser Foundation) which is portable and proven highly effective for the treatment of many neurological issues including traumatic brain injury (TBI) and CTE, depression, post-traumatic stress disorder (PTSD), Alzheimer’s disease/dementia, and Parkinson’s disease.

We have a unique patented infrared laser treatment protocol (held by the Neuro-Laser Foundation) which is portable and proven highly effective for the treatment of many neurological issues including traumatic brain injury (TBI) and CTE, depression, post-traumatic stress disorder (PTSD), Alzheimer’s disease/dementia, and Parkinson’s disease.

Our potential market represents over 128.2 million Americans and cases of diagnosed brain issues continues to grow yearly. In 2014 the CDC reports 2.8M yearly cases of TBI alone.
The 128.2M market represents the following brain disorders:

  • traumatic brain injury (TBI) and subsequent CTE
  • depression
  • post-traumatic stress disorder (PTSD)
  • Alzheimer’s
  • disease/dementia
  • Parkinson’s disease
 

To our knowledge, this is currently the only patented or available treatment worldwide showing actual brain tissue regrowth and neurogenesis.

Treatment will be tailored to the specific needs of the patient. The available services will include: infrared light treatments, hyperbaric oxygen treatments, low dose ketamine infusion therapy, pulsed electromagnetic frequency devices, exercise programs, and guidance on nutritional supplements and cognitive exercises.

Having recently completed the Series A and PPM we have an assertive go-to market strategy and are happy to provide qualified investors with more detailed information. 

Please contact us at invest@neuroluminance.com